BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 29925042)

  • 1. SIRT2 Promotes the Migration and Invasion of Gastric Cancer through RAS/ERK/JNK/MMP-9 Pathway by Increasing PEPCK1-Related Metabolism.
    Li Y; Zhang M; Dorfman RG; Pan Y; Tang D; Xu L; Zhao Z; Zhou Q; Zhou L; Wang Y; Yin Y; Shen S; Kong B; Friess H; Zhao S; Wang L; Zou X
    Neoplasia; 2018 Jul; 20(7):745-756. PubMed ID: 29925042
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Downregulation of SIRT2 Inhibits Invasion of Hepatocellular Carcinoma by Inhibiting Energy Metabolism.
    Huang S; Zhao Z; Tang D; Zhou Q; Li Y; Zhou L; Yin Y; Wang Y; Pan Y; Dorfman RG; Ling T; Zhang M
    Transl Oncol; 2017 Dec; 10(6):917-927. PubMed ID: 28992545
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Upregulated expression of long noncoding RNA SNHG15 promotes cell proliferation and invasion through regulates MMP2/MMP9 in patients with GC.
    Chen SX; Yin JF; Lin BC; Su HF; Zheng Z; Xie CY; Fei ZH
    Tumour Biol; 2016 May; 37(5):6801-12. PubMed ID: 26662309
    [TBL] [Abstract][Full Text] [Related]  

  • 4. WISP-2 in human gastric cancer and its potential metastatic suppressor role in gastric cancer cells mediated by JNK and PLC-γ pathways.
    Ji J; Jia S; Jia Y; Ji K; Hargest R; Jiang WG
    Br J Cancer; 2015 Sep; 113(6):921-33. PubMed ID: 26291058
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transducin (β)-like 1 X-linked receptor 1 promotes gastric cancer progression via the ERK1/2 pathway.
    Zhou Q; Wang X; Yu Z; Wu X; Chen X; Li J; Zhu Z; Liu B; Su L
    Oncogene; 2017 Mar; 36(13):1873-1886. PubMed ID: 27694893
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The SIRT2/cMYC Pathway Inhibits Peroxidation-Related Apoptosis In Cholangiocarcinoma Through Metabolic Reprogramming.
    Xu L; Wang L; Zhou L; Dorfman RG; Pan Y; Tang D; Wang Y; Yin Y; Jiang C; Zou X; Wu J; Zhang M
    Neoplasia; 2019 May; 21(5):429-441. PubMed ID: 30933885
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SIX1 is upregulated in gastric cancer and regulates proliferation and invasion by targeting the ERK pathway and promoting epithelial-mesenchymal transition.
    Xie Y; Jin P; Sun X; Jiao T; Zhang Y; Li Y; Sun M
    Cell Biochem Funct; 2018 Dec; 36(8):413-419. PubMed ID: 30379332
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sirtuin 2 in Endometrial Cancer: A Potential Regulator for Cell Proliferation, Apoptosis and RAS/ERK Pathway.
    Guo Y; Zhao N; Zhou J; Dong J; Wang X
    Technol Cancer Res Treat; 2020; 19():1533033820980781. PubMed ID: 33327875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bradykinin Promotes Cell Proliferation, Migration, Invasion, and Tumor Growth of Gastric Cancer Through ERK Signaling Pathway.
    Wang G; Sun J; Liu G; Fu Y; Zhang X
    J Cell Biochem; 2017 Dec; 118(12):4444-4453. PubMed ID: 28464378
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sirtuin 2 knockdown inhibits cell proliferation and RAS/ERK signaling, and promotes cell apoptosis and cell cycle arrest in multiple myeloma.
    Ding T; Hao J
    Mol Med Rep; 2021 Nov; 24(5):. PubMed ID: 34476507
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-25 promotes gastric cancer proliferation, invasion, and migration by directly targeting F-box and WD-40 Domain Protein 7, FBXW7.
    Gong J; Cui Z; Li L; Ma Q; Wang Q; Gao Y; Sun H
    Tumour Biol; 2015 Sep; 36(10):7831-40. PubMed ID: 25944166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The microRNA-423-3p-Bim Axis Promotes Cancer Progression and Activates Oncogenic Autophagy in Gastric Cancer.
    Kong P; Zhu X; Geng Q; Xia L; Sun X; Chen Y; Li W; Zhou Z; Zhan Y; Xu D
    Mol Ther; 2017 Apr; 25(4):1027-1037. PubMed ID: 28254439
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chitinase 3-like 1-CD44 interaction promotes metastasis and epithelial-to-mesenchymal transition through β-catenin/Erk/Akt signaling in gastric cancer.
    Geng B; Pan J; Zhao T; Ji J; Zhang C; Che Y; Yang J; Shi H; Li J; Zhou H; Mu X; Xu C; Wang C; Xu Y; Liu Z; Wen H; You Q
    J Exp Clin Cancer Res; 2018 Aug; 37(1):208. PubMed ID: 30165890
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sirtinol promotes PEPCK1 degradation and inhibits gluconeogenesis by inhibiting deacetylase SIRT2.
    Zhang M; Pan Y; Dorfman RG; Yin Y; Zhou Q; Huang S; Liu J; Zhao S
    Sci Rep; 2017 Feb; 7(1):7. PubMed ID: 28127057
    [TBL] [Abstract][Full Text] [Related]  

  • 15. KITENIN is associated with tumor progression in human gastric cancer.
    Ryu HS; Park YL; Park SJ; Lee JH; Cho SB; Lee WS; Chung IJ; Kim KK; Lee KH; Kweon SS; Joo YE
    Anticancer Res; 2010 Sep; 30(9):3479-86. PubMed ID: 20944126
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tissue transglutaminase-2 promotes gastric cancer progression via the ERK1/2 pathway.
    Wang X; Yu Z; Zhou Q; Wu X; Chen X; Li J; Zhu Z; Liu B; Su L
    Oncotarget; 2016 Feb; 7(6):7066-79. PubMed ID: 26771235
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rab40b upregulation correlates with the prognosis of gastric cancer by promoting migration, invasion, and metastasis.
    Li Y; Jia Q; Wang Y; Li F; Jia Z; Wan Y
    Med Oncol; 2015 Apr; 32(4):126. PubMed ID: 25790780
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HOXB7 overexpression promotes cell proliferation and correlates with poor prognosis in gastric cancer patients by inducing expression of both AKT and MARKs.
    He X; Liu Z; Xia Y; Xu J; Lv G; Wang L; Ma T; Jiang L; Mou Y; Jiang X; Ma J; Zhao Z; Ni H; Xu W; Ru G; Huang D; Tao H
    Oncotarget; 2017 Jan; 8(1):1247-1261. PubMed ID: 27901487
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated Orai1 and STIM1 expressions upregulate MACC1 expression to promote tumor cell proliferation, metabolism, migration, and invasion in human gastric cancer.
    Xia J; Wang H; Huang H; Sun L; Dong S; Huang N; Shi M; Bin J; Liao Y; Liao W
    Cancer Lett; 2016 Oct; 381(1):31-40. PubMed ID: 27431311
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miR-215 promotes malignant progression of gastric cancer by targeting RUNX1.
    Li N; Zhang QY; Zou JL; Li ZW; Tian TT; Dong B; Liu XJ; Ge S; Zhu Y; Gao J; Shen L
    Oncotarget; 2016 Jan; 7(4):4817-28. PubMed ID: 26716895
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.